CLINICAL_TRIALS
trial_result
· 2014-02-04
Clinical Trial Update: Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer [Phase 2]
Summary
Phase 2 trial evaluating docetaxel before radical prostatectomy in men with high-risk localized prostate cancer; results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beth Israel Deaconess Medical Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-02-04